0.293
Northwest Biotherapeutics Inc Stock (NWBO) Forecast
The Northwest Biotherapeutics Inc (NWBO) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $1.7795, representing a +507.35% increase from the current price of $0.293. The highest analyst price target is $1.833, and the lowest is $1.7261.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month NWBO Price Target
Average 2.2731
(+675.81% Upside)
Long-term NWBO price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Northwest Biotherapeutics Inc financial reports and earnings history, Northwest Biotherapeutics Inc (NWBO) stock could reach $4.0074 by 2030, $8.1313 by 2040 and $14.61 by 2050. See the projected annual prices until 2050 of the Northwest Biotherapeutics Inc stock below:
- Northwest Biotherapeutics Inc (NWBO) is expected to reach an average price of $6.1119 in 2035, with a high prediction of $6.1959 and a low estimate of $5.7903. This indicates an $1,986% rise from the last recorded price of $0.293.
- Northwest Biotherapeutics Inc (NWBO) stock is projected to chart a bullish course in 2040, with an average price target of $8.0475, representing an $2,647% surge from its current level. The forecast ranges from a conservative $7.7089 to a sky-high $8.1313.
- Our analysts predict Northwest Biotherapeutics Inc (NWBO) to jump 3,251% by 2045, soaring from $9.6166 to an average price of $9.8198, potentially reaching $12.08. While $9.6166 is the low estimate, the potential upside is significant.
- Northwest Biotherapeutics Inc (NWBO) stock is expected to climb by 2050, reaching an average of $14.26, a $4,766% jump from its current level. However, a wide range of estimates exists, with high and low targets of $14.61 and $13.91, respectively, highlighting the market's uncertainty.
Northwest Biotherapeutics Inc Stock (NWBO) Year by Year Forecast
Northwest Biotherapeutics Inc Stock (NWBO) Price Forecast for 2025
Northwest Biotherapeutics Inc Stock (NWBO) is expected to reach an average price of $2.1385 in 2025, with a high prediction of $2.5987 and a low estimate of $1.6783. This indicates an +629.86% rise from the last recorded price of $0.293.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
April, 2025 | $1.7769 | $1.7261 | $1.833 | +506.47% |
May, 2025 | $1.9689 | $1.769 | $1.9849 | +571.99% |
June, 2025 | $1.9188 | $1.8898 | $2.0069 | +554.88% |
July, 2025 | $2.0006 | $1.8878 | $2.0727 | +582.79% |
August, 2025 | $2.1617 | $1.9935 | $2.5987 | +637.77% |
September, 2025 | $1.9685 | $1.9096 | $2.4466 | +571.84% |
October, 2025 | $2.0494 | $1.9275 | $2.1332 | +599.45% |
November, 2025 | $2.1153 | $2.0489 | $2.2063 | +621.95% |
December, 2025 | $2.1752 | $2.0972 | $2.1992 | +642.40% |
Northwest Biotherapeutics Inc Stock (NWBO) Price Forecast for 2026
The predicted value for Northwest Biotherapeutics Inc (NWBO) in 2026 is set at an average of $2.6691. Estimates vary from a peak of $3.245 to a trough of $2.0931, indicating an +810.95% surge from the present price of $0.293.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2026 | $2.6861 | $2.1702 | $2.8061 | +816.77% |
February, 2026 | $2.5462 | $2.3841 | $2.8201 | +769.00% |
March, 2026 | $2.1559 | $2.0931 | $2.676 | +635.81% |
April, 2026 | $2.3639 | $2.152 | $2.3798 | +706.79% |
May, 2026 | $2.3249 | $2.2928 | $2.4058 | +693.46% |
June, 2026 | $2.4315 | $2.3067 | $2.5036 | +729.86% |
July, 2026 | $2.6085 | $2.4284 | $3.0416 | +790.29% |
August, 2026 | $2.3395 | $2.2766 | $2.9055 | +698.46% |
September, 2026 | $2.4364 | $2.3065 | $2.5202 | +731.53% |
October, 2026 | $2.5183 | $2.4398 | $2.6053 | +759.48% |
November, 2026 | $2.5981 | $2.5112 | $2.6221 | +786.74% |
December, 2026 | $3.125 | $2.5971 | $3.245 | +966.57% |
Northwest Biotherapeutics Inc Stock (NWBO) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Northwest Biotherapeutics Inc (NWBO) is $3.083, with a high forecast of $3.7059 and a low forecast of $2.4601. This indicates an +952.22% increase from the last price of $0.293.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2027 | $3.001 | $2.831 | $3.263 | +924.25% |
February, 2027 | $2.5075 | $2.4601 | $3.1349 | +755.82% |
March, 2027 | $2.7589 | $2.496 | $2.7748 | +841.59% |
April, 2027 | $2.7358 | $2.6957 | $2.8048 | +833.72% |
May, 2027 | $2.8624 | $2.7256 | $2.9345 | +876.93% |
June, 2027 | $3.0554 | $2.8633 | $3.4845 | +942.81% |
July, 2027 | $2.721 | $2.6436 | $3.3643 | +828.67% |
August, 2027 | $2.8233 | $2.6855 | $2.9071 | +863.60% |
September, 2027 | $2.9212 | $2.8308 | $3.0043 | +897.00% |
October, 2027 | $2.984 | $2.9182 | $3.0041 | +918.43% |
November, 2027 | $3.5639 | $2.9861 | $3.6839 | +1,116% |
December, 2027 | $3.4559 | $3.277 | $3.7059 | +1,079% |
Northwest Biotherapeutics Inc Stock (NWBO) Price Forecast for 2028
In 2028, Northwest Biotherapeutics Inc (NWBO) is projected to reach an average price of $3.488, with a high projection of $4.1488 and a low estimate of $2.8271. This indicates an +1,090% rise from the last price of $0.293.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2028 | $2.9139 | $2.8271 | $3.5938 | +894.50% |
February, 2028 | $3.1538 | $2.918 | $3.1698 | +976.39% |
March, 2028 | $3.1467 | $3.0987 | $3.2037 | +973.97% |
April, 2028 | $3.3175 | $3.1446 | $3.3405 | +1,032% |
May, 2028 | $3.5023 | $3.2755 | $3.9274 | +1,095% |
June, 2028 | $3.088 | $3.0106 | $3.8232 | +953.92% |
July, 2028 | $3.2103 | $3.0624 | $3.2941 | +995.67% |
August, 2028 | $3.3242 | $3.2218 | $3.4032 | +1,035% |
September, 2028 | $3.4029 | $3.3251 | $3.4191 | +1,061% |
October, 2028 | $4.0028 | $3.409 | $4.1228 | +1,266% |
November, 2028 | $3.9108 | $3.7199 | $4.1488 | +1,235% |
December, 2028 | $3.2575 | $3.1941 | $4.0527 | +1,012% |
Northwest Biotherapeutics Inc Stock (NWBO) Price Forecast for 2029
The 2029 price forecast for Northwest Biotherapeutics Inc Stock (NWBO) is $3.9228 on average, with a high prediction of $4.5917 and a low estimate of $3.2539. This represents an +1,239% increase from the previous price of $0.293.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2029 | $3.5488 | $3.2539 | $3.5647 | +1,111% |
February, 2029 | $3.5577 | $3.5016 | $3.6027 | +1,114% |
March, 2029 | $3.7445 | $3.5596 | $3.7674 | +1,178% |
April, 2029 | $3.9492 | $3.7064 | $4.3702 | +1,248% |
May, 2029 | $3.455 | $3.3776 | $4.2821 | +1,079% |
June, 2029 | $3.5805 | $3.4374 | $3.5923 | +1,122% |
July, 2029 | $3.7271 | $3.5745 | $3.8022 | +1,172% |
August, 2029 | $3.8218 | $3.7321 | $3.834 | +1,204% |
September, 2029 | $4.0068 | $3.8319 | $4.0268 | +1,268% |
October, 2029 | $4.3657 | $4.0416 | $4.5917 | +1,390% |
November, 2029 | $3.6325 | $3.5611 | $4.5115 | +1,140% |
December, 2029 | $3.9437 | $3.6329 | $3.9597 | +1,246% |
Northwest Biotherapeutics Inc Stock (NWBO) Price Forecast for 2030
Northwest Biotherapeutics Inc Stock (NWBO) is expected to reach an average price of $4.3896 in 2030, with a high forecast of $5.0346 and a low forecast of $3.7446. This signifies an +1,398% surge from the last price of $0.293.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2030 | $3.9686 | $3.9046 | $4.0074 | +1,254% |
February, 2030 | $4.1714 | $3.9745 | $4.1943 | +1,324% |
March, 2030 | $4.4381 | $4.1373 | $4.8131 | +1,415% |
April, 2030 | $3.822 | $3.7446 | $4.741 | +1,204% |
May, 2030 | $3.9635 | $3.8124 | $3.9753 | +1,253% |
June, 2030 | $4.1171 | $3.9615 | $4.2011 | +1,305% |
July, 2030 | $4.2408 | $4.1061 | $4.2509 | +1,347% |
August, 2030 | $4.4417 | $4.2548 | $4.4617 | +1,416% |
September, 2030 | $4.8205 | $4.4805 | $5.0346 | +1,545% |
October, 2030 | $4.0075 | $3.9281 | $4.9704 | +1,268% |
November, 2030 | $4.2298 | $4.0119 | $4.2684 | +1,344% |
December, 2030 | $4.3795 | $4.2547 | $4.4183 | +1,395% |
Cap:
|
Volume (24h):